Legend Biotech Corporation
Legend Biotech Corporation (LEGN) Revenue
Annual & quarterly revenue history · segment & region breakdown
LEGN · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsLegend Biotech Corporation trailing twelve-month (TTM) revenue is $1.14B, an increase of 64.04% year-over-year from $1.03B in FY2025.
Revenue trend
2025 – 2017 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $1.03B | +$0.40B | +64.04% |
| 2024-12-31 | $0.63B | +$0.34B | +119.97% |
| 2023-12-31 | $0.29B | +$0.17B | +143.70% |
| 2022-12-31 | $0.12B | +$0.05B | +70.00% |
| 2021-12-31 | $0.07B | -$0.01B | -8.23% |
| 2020-12-31 | $0.07B | +$0.01B | +21.36% |
| 2019-12-31 | $0.06B | +$0.01B | +25.78% |
| 2018-12-31 | $0.05B | +$0.03B | +108.24% |
| 2017-12-31 | $0.02B | — | — |
Compare revenue vs peers
BiotechnologyCompare LEGN revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Legend Biotech Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Legend Biotech Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Legend Biotech Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
LEGN revenue · 5 questionsLEGN's trailing twelve-month (TTM) revenue is $1.14B. That is an increase of 64.04% year-over-year from $1.03B in FY2025.
▸ Source: FMP · Legend Biotech Corporation SEC filings · GAAP · Legend Biotech Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026